T1	intervention 0 11	Dexrazoxane
T2	condition 63 98	chemotherapy-induced cardiotoxicity
T3	eligibility 194 254	breast cancer with concurrent type 2 diabetes mellitus (DM2)
T4	total-participants 256 262	Eighty
T5	control 341 358	chemotherapy only
T6	outcome 865 902	baseline systole or diastole function
T11	outcome 1158 1178	superoxide dismutase
T13	outcome 1288 1321	Serum superoxide dismutase levels
T7	outcome 1001 1017	reductions in Ea
T8	outcome 1044 1076	elevations in E/Ea and Tei index
